Location: | London |
---|---|
Salary: | £55,144 to £65,073 per annum |
Hours: | Part Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 15th September 2025 |
---|---|
Closes: | 25th September 2025 |
Job Ref: | MED05424 |
Location: Hammersmith Campus
About the role
To develop RNA regulation of a target gene as part of a European Consortium funded by a Horizon 2020 grant who are developing a computational and experimental pipeline to identify and validate an antiviral for a new emerging or re-emerging virus causing a human disease and ultimately identify at least one antiviral vaccine against a broad spectrum of potential emerging and re-emerging viruses as listed by the WHO. This position will draw on Professor Habib’s experience of RNA regulation.
What you would be doing
You will be working in the Francis Fraser laboratory to find the most suitable gene for an anti-viral vaccine.
When the target gene has been identified you will need to assess its activity in vitro.
You will be expected to attend and participate in grant teleconferences
You will need to present your work as requested.
What we are looking for
What we can offer you
Further information
This role is Part-time (0.6 FTE, fixed term until 24 February 2028 based at Hammersmith Campus (East Acton).
If you require any further details on the role please contact:
Professor Nagy Habib – nagy.habib@imperial.ac.uk
Type / Role:
Subject Area(s):
Location(s):